History

A list of downloadable documents created during development.

Background information

Rheumatoid arthritis (after the failure of previous anti-rheumatic drugs) - golimumab: equality impact assessment

Rheumatoid arthritis (after failure of previous antirheumatic drugs) - golimumab: final appraisal determination

Rheumatoid arthritis (after failure of previous antirheumatic drugs) - golimumab: appraisal consultation

Rheumatoid arthritis (after failure of previous antirheumatic drugs) - golimumab: final matrix

Rheumatoid arthritis (after failure of previous antirheumatic drugs) - golimumab: final scope

Rheumatoid arthritis (after failure of previous antirheumatic drugs) - golimumab: Institute's response to consultee and commentator comments on the draft scope

Letter for consultees and commentators on the suspension of this appraisal.

Rheumatoid arthritis (after failure of previous antirheumatic drugs) - golimumab: Institute's response to consultee and commentator comments on the provisional matrix

Rheumatoid arthritis (after failure of previous antirheumatic drugs) - golimumab: draft scope

Rheumatoid arthritis (after failure of previous antirheumatic drugs) - golimumab: provisional matrix